FDA ADVERSE_DETERMINATION_LETTER - Unknown Company - July 12, 2010

FDA ADVERSE_DETERMINATION_LETTER for Unknown Company on July 12, 2010. Product: N/A. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA ADVERSE_DETERMINATION_LETTER for Unknown Company on July 12, 2010. Product: N/A. Access full analysis and detailed observations.

Violation Codes

21 CFR 600

FD&C Act 801(a)(3)

21 CFR 606.165(a)

21 U.S.C. 352(a)

21 U.S.C. 321(g)

21 CFR 606.170(a)

21 CFR 210

21 CFR 606.100(b)

21 U.S.C. 351(a)(2)(B)

FD&C Act 905(j)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Inspection Date

July 12, 2010

Product Type

Office

Baltimore District Office

People

Chris Hrouda (J.)

ID: c96c8d00-7ab7-4b35-949d-3b1e9ec87c44

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox